US28106W1036
US28106W1036
Editas Medicine, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 445.38M EUR | 497.44M EUR | 241.82M EUR | 200.63M EUR |
Enterprise Value | 240.03M EUR | 331.14M EUR | 135.46M EUR | 72.08M EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -3.85x | -- | -- | -- |
Price to Sales | 9.48x | 10.58x | 6.25x | 5.59x |
Price to Book | 4.23x | 4.72x | 54.86x | 7.35x |
EV/Revenue | 5.11x | 7.04x | 3.5x | 2.01x |
EV/EBITDA | -2.96x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -9.95% | -24.23% | -58.35% | -58.78% |